FindTrial
Sign In

Clinical Study on Auricular Acupoint Therapy for Low Back Pain in Elderly Patients with Multiple Myeloma (Qi and Blood Deficiency Syndrome)

The Effect of Auricular Acupoint Therapy Based on Self-Transcendence Theory on Low Back Pain in Elderly Patients with Multiple Myeloma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000826
Enrollment
Unknown
Registered
2025-04-22
Start date
2023-01-01
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low Back Pain in Elderly Patients with Multiple Myeloma

Interventions

Control Group:Standard Care
Experimental Group:Auricular Acupoint Therapy based on Self-Transcendence Theory

Sponsors

Department of Hematology and Oncology The First Hospital of Hunan University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
55 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: 1. Diagnosis of multiple myeloma per *Chinese Guidelines for Diagnosis and Treatment of Multiple Myeloma*, KPS score =60, age 55–80 years. 2. Cancer-related low back pain with NRS score =4. 3. No cognitive/psychiatric disorders; capable of understanding assessments and complying with treatment. 4. Signed informed consent obtained.

Exclusion criteria

Exclusion criteria: Exclusion Criteria: 1. Severe cardiac, hepatic, renal, or hematopoietic diseases (non-cancer), or psychiatric disorders. 2. Allergy to ear acupoint patches. 3. Active inflammation, eczema, ulcers, frostbite, or significant scarring in the ear region.

Design outcomes

Primary

MeasureTime frame
Japanese Orthopaedic Association,JOA;visual analogue scale;—

Secondary

MeasureTime frame
Self - Transcendence Scale;Patient Satisfaction with Nursing Care;GDS-15;EORCT QLQ-C30 V3.0;—

Countries

China

Contacts

Public ContactZhang Ping

The First Hospital of Hunan University of Chinese Medicine

3165552520@qq.com15096221421

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026